Healthy Participants
Conditions
Interventions
RGB-19 injection or Tocilizumab injection
Sponsors
Karibe Yusuke
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Male volunteers who voluntarily wish to participate in the study, have the capacity to provide consent, and have provided written informed consent to participate in the study. Volunteers from 20 to 40 years of age (both inclusive) when signing informed consent.
Exclusion criteria
Exclusion criteria: Volunteers previously exposed to tocilizumab, any other IL-6 inhibitors, or IL-6 receptor inhibitors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum serum drug concentration (Cmax) AUC from 0 hours (immediately before administration) to infinity (AUCinf) | — |
Contacts
Public ContactPublic relations
Mochida Pharmaceutical Co., Ltd.
Outcome results
None listed